Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gray

Showing results (1081-1090 of 1,555) with videos related to

Pageof 156
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2021
Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferaseZebulon G Levine, Sarah C Potter, Cassandra M Joiner, et al.
Leukemia|November 23, 2016
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathwayY Shen, C S Park, K Suppipat, et al.
Journal of Medicinal Chemistry|December 2, 2025
Selective CDK6 Degradation via the KLHDC2 E3 Ubiquitin LigaseEunhye Jeon, Younghoon Kim, Hyunwoo Ahn, et al.
Cancer|March 1, 1996
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposisD C de Silva, M F Wright, D A Stevenson, et al.
Journal of the American Chemical Society|September 17, 2025
Discovery of BRD9 Molecular Glue Degraders That Spare CardiomyocytesWoong Sub Byun, Zhe Zhuang, Anna P Hnatiuk, et al.
Applied and Environmental Microbiology|August 13, 2013
U(VI) reduction by diverse outer surface c-type cytochromes of Geobacter sulfurreducensRoberto Orellana, Janet J Leavitt, Luis R Comolli, et al.
Molecular Cancer Therapeutics|December 4, 2013
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 lossEllen M Beauchamp, Brittany A Woods, Austin M Dulak, et al.
Molecular Cancer Therapeutics|October 17, 2013
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cellsHelena Mistry, Grace Hsieh, Sara J Buhrlage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung CancerCurtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
Breast Cancer Research and Treatment|July 3, 2025
A single bout of resistance or high-intensity interval training increases anti-cancer myokines and suppresses cancer cell growth in vitro in survivors of breast cancerFrancesco Bettariga, Dennis R Taaffe, Cristina Crespo-Garcia, et al.
Pageof 156

Showing results (1081-1090 of 1,555) with videos related to

Sort By:
Pageof 156
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2021
Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferaseZebulon G Levine, Sarah C Potter, Cassandra M Joiner, et al.
Leukemia|November 23, 2016
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathwayY Shen, C S Park, K Suppipat, et al.
Journal of Medicinal Chemistry|December 2, 2025
Selective CDK6 Degradation via the KLHDC2 E3 Ubiquitin LigaseEunhye Jeon, Younghoon Kim, Hyunwoo Ahn, et al.
Cancer|March 1, 1996
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposisD C de Silva, M F Wright, D A Stevenson, et al.
Journal of the American Chemical Society|September 17, 2025
Discovery of BRD9 Molecular Glue Degraders That Spare CardiomyocytesWoong Sub Byun, Zhe Zhuang, Anna P Hnatiuk, et al.
Applied and Environmental Microbiology|August 13, 2013
U(VI) reduction by diverse outer surface c-type cytochromes of Geobacter sulfurreducensRoberto Orellana, Janet J Leavitt, Luis R Comolli, et al.
Molecular Cancer Therapeutics|December 4, 2013
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 lossEllen M Beauchamp, Brittany A Woods, Austin M Dulak, et al.
Molecular Cancer Therapeutics|October 17, 2013
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cellsHelena Mistry, Grace Hsieh, Sara J Buhrlage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung CancerCurtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
Breast Cancer Research and Treatment|July 3, 2025
A single bout of resistance or high-intensity interval training increases anti-cancer myokines and suppresses cancer cell growth in vitro in survivors of breast cancerFrancesco Bettariga, Dennis R Taaffe, Cristina Crespo-Garcia, et al.
Pageof 156